Search results
Plus Therapeutics: Targeting Brain Cancer with Rifle-Shot Precision
IPO-Edge.com via Yahoo Finance· 1 year agoPlus Therapeutics, Inc. (Nasdaq: PSTV) specializes in targeted radiation treatments Rather than...
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoPlus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript March 5, 2024 Plus...
Plus Therapeutics Shares Surge On Positive Data From Lead Brain Cancer Candidate
Benzinga via Yahoo Finance· 2 years agoPlus Therapeutics Inc (NASDAQ: PSTV) presented data from two ongoing trials of its lead...
Lisata's (LSTA) LSTA1 Gets FDA's RPDD Tag for Osteosarcoma
Zacks via Yahoo Finance· 3 months agoLisata Therapeutics, Inc. LSTA announced that the FDA has granted a Rare Pediatric Disease...
Factbox-These are the leaders who want to reshape Goldman Sachs
Reuters via Yahoo Finance· 2 years ago(Reuters) - Goldman Sachs Group Inc unveiled a plan to reorganize its business into three units in...
Lisata (LSTA) Stock Up More Than 35% in 3 Months: Here's Why
Zacks via Yahoo Finance· 5 months agoLisata Therapeutics, Inc. LSTA shares have rallied 35.3% in the past three months compared with the...
Why TransCode Therapeutics Stock Is Trading Higher Premarket Today
Benzinga via Yahoo Finance· 1 year agoTransCode Therapeutics Inc (NASDAQ: RNAZ) announced acceptance for publication by Frontiers in...
VBI Vaccine (VBIV) Inks Deal With Agenus for Brain Cancer Study
Zacks via Yahoo Finance· 2 years agoVBI Vaccines (VBIV) enters into a partnership with Agenus to conduct a study evaluating the former's...
Plus Therapeutics Highlights Updates On Lead Program In Brain Cancer Indications
Benzinga via Yahoo Finance· 2 years agoPlus Therapeutics Inc (NASDAQ: PSTV) presented data from two ongoing trials evaluating its lead...
Black Diamond Therapeutics Inc (BDTX) Reports Q3 2023 Financial Results and Corporate Update
GuruFocus.com via Yahoo Finance· 7 months agoBlack Diamond Therapeutics Inc (NASDAQ:BDTX) reported Q3 2023 financial results, with a net loss of...